JGL Scientific Advisory Board

JGL SCIENTIFIC ADVISORY BOARD (JGL SAB) is an independent, international, advisory body of eminent scientists and experts whose areas of interest fall into the company's strategic therapeutic areas - influenza and cold, ophthalmology and dermatology, and operating in Europe and the UK, Russia, Ukraine, Turkey and through its network - in other global markets.

It is composed of ten experts, internationally recognised in their fields of work - pharmacology, preclinical, clinical and regulatory stages of drug development, pharmaceutical product design, drug delivery systems and technologies, and practical regulatory and clinical and industrial experience.

The main goals for the SAB meeting

- Strengthen the scientific profile of the JGL research and development project / product portfolio
- Network and share relevant, science-based knowledge and ideas
- Review, challenge and advise the JGL team on ongoing R&D projects
- Provide scientific explanations and adequacy of performance data and plans
- Work with the JGL team and other SAB members to gather additional ideas for the portfolio and identify new projects with a sound scientific rationale
- Present the area of ​​own expertise through lectures and discussions
- Advise the JGL Board of Directors in special strategic decisions



Prof. dr. sc. Henning H. Blume, MD, is the founder and owner of SocraTeca C&S (Concepts and Strategies in Clinical Drug Development) and Professor of Pharmacy at the University of Frankfurt. He is a globally recognized expert in the broad field of biopharmaceuticals who supports numerous clients with his highly sophisticated consulting activities. Born in 1947, he received his doctorate from the University of Frankfurt in 1973, and completed his postdoctoral research in 1982 as an assistant professor at the Faculty of Pharmacy, University of Frankfurt. His areas of research include biopharmaceutical and pharmacokinetic research, with special emphasis on the characterization of drug bioavailability and bioequivalence. He has published more than 230 scientific papers and is a member of numerous international scientific institutions in the field of biopharmaceuticals and clinical pharmacology. The internationally renowned Semmelweis University of Education and Research awarded him an honorary doctorate for his outstanding contribution to the advancement of science.


Prof. dr. sc. Vasil Ivanovič Popovič, MD is the head of the Department of Otorhinolaryngology and Head and Neck Surgery of the National University of Ivano-Frankivsk in Ukraine and one of the most respected ENT surgeons, pediatric otorhinolaryngologists and ENT oncologists in Russia and Ukraine. In 1985 he graduated from the Department of Treatment at the Tomsk Medical Institute, and continued his postgraduate education at the Scientific Research Institute for Cancer at the Tomsk Scientific Center of the Russian Academy of Medical Sciences. He is defending his doctoral dissertation at the same institute. He is the author and co-author of more than 400 scientific papers, monographs and methodological recommendations, and leads a team that deals with two scientific discoveries in the field of medicine, which are related to the problems of rhinosinusitis. He has been awarded the highest scientific awards of the European, Belgian and Russian academies of science, awards of numerous foreign associations for inventors. He was the person of the year in Ukraine (2007), the winner of a regional award named H. Tersenov and the best scientist of the year in the Ivanko-Frankivsk region. Under his scientific supervision, the Center for Microsurgery and Reconstructive Surgery of ENT Organs, the Center for Endoscopic Surgery of Pediatric ENT Organs and the Center for Audioverbal Rehabilitation of Children with Hearing Impairment are organized and function.


Prof. dr. sc. Stipan Jonjić was born in 1953 and he is a professor and head of the Department of Histology and Embryology, and the head of the Center for Proteomics at the Medical Faculty of the University of Rijeka. His research interests include immunology, viral pathogenesis, vaccines and immunotherapy. In 2012, Jonjić became the first Croatian scientist to be admitted to Leopoldin, the German National Academy of Sciences, and in 2015 he was admitted to the European Academy of Microbiology. In 2006, he founded the Center for Proteomics, which has become one of the most recognizable scientific institutions in Croatia. He is the first Croatian scientist to receive a project in 2012 from the European Research Council (ERC), a scientific research body that funds projects solely on the basis of excellence. He has led projects at the U.S. National Institutes of Health and the Viral Immunology and Vaccine Science Center. The work of prof. Jonjic resulted in a number of important discoveries in the field of viral immunology and vaccinology. He is the author of more than 250 scientific papers, many of which have been published in the most prestigious scientific journals, which makes him one of the most successful Croatian scientists. He has given more than 200 lectures at international scientific conferences and institutions around the world, and collaborates with a large number of world scientists in the field of viral immunology.


Marina A. Mokronosova was born in 1958, she graduated in allergology and immunology at the Medical Institute in Yekaterinburg (Russia) in 1983, and since 1987, when she received her doctorate, she has been working and running the allergology department of the prestigious I.I. Mechnikov. Her field of scientific and practical interests for 40 years includes the study of atopic dermatitis, allergic rhinitis, bronchial asthma, food and drug allergies, and molecular allergology. She is the author of more than 180 scientific papers in leading Russian and international publications, and more than a dozen doctoral dissertations have been done under her mentorship. She is a participant and initiator of numerous international congresses, scientific and professional conferences and symposium. She is a regular lecturer at the International School of Molecular Allergology "INUNIMAI" and the general director of the Russian allergological center "Ado".


Prof. dr. sc. Özgen Özer, MD was born in 1962 in Ankara (Turkey), she is the head of the Department of Pharmaceutical Technology at the Faculty of Pharmacy of Ege University (Izmir, Turkey) where she received her doctorate in 1992. Her research interests include the design and formulation of dermal / transdermal products, the characterization and analysis of such products, liposomes, nanoparticles, stability, and the procedures required for the commercialization of product formulations. She has a very successful scientific and mentoring career, 12 patents, more than 250 national and international presentations, publications in more than 150 publications, and research work in more than 50 projects, including eight awards for the best poster presentations, three best doctoral theses and the top five projects. He collaborates with a large number of eminent world scientists in the field of dermatology. Özer is the co-founder and CEO of Dermis Pharma Health and Cosmetic Products Inc. which was founded in 2016 in Turkey.


Dr. sc. Jag Ahluwalia, MD is an experienced leader in the field of regulatory affairs and quality. In her rich professional career, leading positions in Ranbaxy (India), Pliva (Croatia), Xellia Pharmi (Denmark) and Kinedexe UK (own company) stand out. Born in 1962 in Uganda, she holds a PhD in toxicology from the University of Surrey and has more than 35 years of experience in the pharmaceutical industry, from regulatory affairs, quality and product development, to business development. In 2014 she started three pharmaceutical companies in the UK, and her expertise lies in the successful launch of molecules that have been developed and registered using a virtual environment in a cost-effective way. In the areas of industrial pharmaceutical practice and registration, she operates in the EU, the UK, the US, Canada, Asia, Australia and Latin America. Under her leadership, a number of projects have been successfully registered and launched, including FTF products in the United States. Thanks to her significant international experience, Jag Ahluwalia supports numerous projects of registration / entry of medicines into global markets.


Prof. dr. sc. Vladimir Trkulja, MD is a professor of pharmacology at the Medical Faculty of the University of Zagreb. He finished primary and secondary school and the Faculty of Medicine in Zagreb. After completing his internship as a doctor, he participated in the Homeland War and then got a job at the Department of Pharmacology, Faculty of Medicine, University of Zagreb. He received his master's degree in 1995 and his doctorate in 1997. He is an editor and reviewer in numerous scientific publications, and the author or co-author of 115 professional papers. He gained experience in drug development and regulation, evaluation of therapeutic interventions, pharmacokinetics and systematic reviews / meta-analyzes at the Center for Genetic Engineering and Biotechnology (Havana, Cuba), Baxter Healthcare International Renal Division (Chicago, USA), Serum Institute Pune, India), Fumedica GmbH (Herne, Germany), Genera (Zagreb, Croatia), Hindustan Antibiotics (Pune, India) and Elanex Pharma (Seattle, USA).


Asst.prof.ph.d. Sonja Jandroković, MD was born in 1969 in Beijing. She is the head of the Day Hospital and One-Day Surgery at the Clinic for Eye Diseases, University Hospital Center Zagreb. After graduating from the Medical Faculty of the University of Zagreb in 1993, she specialized in ophthalmology, and chose glaucomatology as her specialization. She received her PhD in 2017 in the study of "Biomedicine and Health" at the Faculty of Medicine, University of Zagreb. She actively participates in numerous scientific and professional conferences in the country and abroad, as well as in first category courses and evaluated scientific lectures. She is the author or co-author of 16 scientific and professional papers and several publications in journals. From the academic year 2011/2012 she participates in the teaching of the Faculty of Medicine, University of Zagreb, and has also lectured at the university postgraduate specialist studies "Ophthalmology" and "Ophthalmology and Optometry". She is the co-leader of the "Glaucoma" course.


Born in 1974, Andreas Bilstein is an experienced scientist, consultant and CEO of Urastech with many years of experience in the pharmaceutical industry. His areas of interest include medical product development, business development, clinical trial management, biotechnology, and regulatory requirements and management. His professional career (2007-2019) is primarily related to the global company Bitop AG (Dortmund, Germany) where he was a member of the Executive Board and CEO of scientific and technological operations, responsible for new product development, research and development, quality management , regulatory affairs and production. Dr. Bilstein received his PhD in 2005 from the Institute of Biochemistry, Faculty of Medicine, University of Cologne.prof. 


Prof. dr. sc. Jasmina Lovrić was born in 1977. She completed her studies in pharmacy at the Faculty of Pharmacy and Biochemistry, University of Zagreb (FBF) in 2001, and her doctorate in pharmaceutical sciences in 2006. During her doctoral studies, she spent three years at McGill University (Montreal, Canada). For her doctoral dissertation in 2006, she was awarded the prize of the Society of University Teachers and Other Scientists. As a Research Fellow in 2006, she joined the FBF Department of Pharmaceutical Technology. Three years later, she acquired the scientific-teaching title of assistant professor, and in 2015 the scientific-teaching title of associate professor. Scientific activity of dr. sc. Lovrić resulted in the publication of 38 highly scientific papers, two chapters in scientific books and 60 conference papers. She is the supervisor of two doctoral theses, 34 diploma theses and five specialist theses. Her special areas of expertise are technologies, characterization and delivery systems for products in ophthalmology. She was the Vice-Dean for Science and Research at the Faculty of Pharmacy and Biochemistry for two terms, and since October 2020 she has been the Dean of the Faculty of Pharmacy and Biochemistry.

To make this website run properly and to improve your experience, we use cookies. For more detailed information, please check our Privacy and personal data protection.

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.